Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Firm Strategy Vignettes
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnCaso HBS-810087-EIniciativa emprendedoraThese three vignettes present various issues around the strategy and management of a private equity firm. In one, a senior partner must decide how to manage an over-extended colleague and how to reduce the risk of the firm's portfolio; in the second, a limited partner must decide how to respond to tensions between general partners in a fund, and in the third, the general partners must decide whether to invest in an intriguing opportunity that lie...Desde 8,20 €
-
New Enterprise Associates
Hardymon, G. Felda; Nicholas, TomCaso HBS-813097-EIniciativa emprendedoraNEA was established in 1977 and it subsequently morphed into one of the largest venture capital firms in the world. Despite its size and significance, some other firms established during the same era such as Kleiner-Perkins and Sequoia (both were established in 1972), are arguably better-known. No venture firm, however, can parallel NEA in terms of its scale and its commitment to organizational and operational innovation. From early on the founde...Desde 8,20 €
-
Brazos Partners and Cheddar's Inc., Teaching Note
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnNota del Instructor HBS-808055-EFinanzasTeaching Note for [806069].Desde 0,00 €
-
Adams Capital Management: Fund IV, Teaching Note
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnNota del Instructor HBS-808053-EIniciativa emprendedoraTeaching Note to (806-077).Desde 0,00 €
-
Venture Capital Vignettes: Difficult Financings
Hardymon, G. Felda; Leamon, AnnCaso HBS-809003-EFinanzasThese three short vignettes depict investment professionals considering difficult financings for companies in their portfolios. For one reason or another, each company has under-performed expectations. Should the protagonist recommend that the firm participate or not, or should he try to revise it? Can the firm exercise any influence, and are the potential gains worth the time and effort that will be required?Desde 8,20 €
-
Creative Capital: Sustaining the Arts
Hardymon, G. Felda; Leamon, AnnCaso HBS-810098-EIniciativa emprendedoraCreative Capital provides grants to individual artists using a venture capital model-the money comes with guidance and governance. Artists receive money as milestones are reached and also receive guidance on managing their lives and business to increase their sustainability. But as Ruby Lerner, CEO of Creative Capital, looks to the organization's next decade, how can she ensure the sustainability of this high-touch, uniquely individual model?Desde 8,20 €
-
Tad O'Malley: December 2004, Teaching Note
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnNota del Instructor HBS-808049-ELiderazgo y Dirección de personasTeaching Note to (806-024).Desde 0,00 €
-
The Canada Pension Plan Investment Board, Teaching Note
Lerner, Josh; Hardymon, G. Felda; Leamon, AnnNota del Instructor HBS-812069-EEconomíaTeaching Note for 809-073.Desde 0,00 €
-
Milliway Capital: Battening Down the Hatches
Lerner, Josh; Hardymon, G. Felda; Leamon, AnnCaso HBS-809072-EFacing the downturn in late 2008, the partners in a West-Coast venture capital firm are trying to decide how to manage their portfolio companies and whether to make new investments. Not only must they consider the particulars of each company individually, but they must also think about how to manage the entire firm's portfolio.Desde 8,20 €
-
Kleiner-Perkins and Genentech: When Venture Capital Met Science
Hardymon, G. Felda; Nicholas, TomCaso HBS-813102-EIniciativa emprendedoraGenentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into viable therapeutic products with mass market appeal, something that most scientists agreed was at least a decade away. The founders, Herbert Boyer and Robert Swanson had limited fina...Desde 8,20 €